Drug resistance profile among HIV-1 infections experiencing ART with low-level viral load in Guangdong China during 2011–2022: A retrospective study
Y Lan, X Ling, X Deng, Y Lin, J Li, L Li… - Infection and Drug …, 2023 - Taylor & Francis
Background Antiretroviral therapy (ART) efficiently reduces the morbidities and mortalities
caused by HIV-1 infection and prevents the HIV epidemic. However, virologic failure (VF) …
caused by HIV-1 infection and prevents the HIV epidemic. However, virologic failure (VF) …
High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana
PT Mokgethi, WT Choga, D Maruapula… - Frontiers in …, 2024 - frontiersin.org
Background Approximately 30,000 non-citizens are living with HIV in Botswana, all of whom
as of 2020 are eligible to receive free antiretroviral treatment (ART) within the country. We …
as of 2020 are eligible to receive free antiretroviral treatment (ART) within the country. We …
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors
J Shi, G Ying, R Zheng, Z Zhang - HIV medicine, 2024 - Wiley Online Library
Background People living with HIV (PLWH) and receiving antiretroviral therapy (ART) have
a goal of achieving and maintaining viral suppression; however, the existence of PLWH that …
a goal of achieving and maintaining viral suppression; however, the existence of PLWH that …
Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China
J Liu, C Li, Y Sun, C Fu, S Wei, X Zhang, J Ma… - Scientific Reports, 2024 - nature.com
Although most people living with HIV (PLWH) receiving antiretroviral therapy (ART) achieve
continuous viral suppression, some show detectable HIV RNA as low-level viremia (LLV)(50 …
continuous viral suppression, some show detectable HIV RNA as low-level viremia (LLV)(50 …
High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in …
OT Choga, GM Lemogang, WT Choga… - Journal of …, 2025 - academic.oup.com
Objectives We assessed HIV-1 drug resistance profiles among people living with HIV
(PLWH) with detectable viral load (VL) and on dolutegravir-based antiretroviral therapy …
(PLWH) with detectable viral load (VL) and on dolutegravir-based antiretroviral therapy …
[HTML][HTML] Performance of an in-house multiplex PCR assay for HIV-1 drug resistance testing–A cheaper alternative
TL Fortuin, P Nkone, A Glass, R Viana, K Moeng… - Journal of Virological …, 2024 - Elsevier
Background Currently, most HIV drug resistance PCR assays amplify the protease-reverse
transcriptase (PR-RT) fragment separately from the integrase (IN) fragment. The aim of this …
transcriptase (PR-RT) fragment separately from the integrase (IN) fragment. The aim of this …